Obviously the Moly proposal was a good deal for Moly shareholders but wont help us if we get gazumped by an alternative bid
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025